These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 321158)

  • 1. A defect of the alternative pathway of complement.
    Soothill JF; Harvey BA
    Clin Exp Immunol; 1977 Jan; 27(1):30-3. PubMed ID: 321158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M; Valdimarsson H
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
    Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
    Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast opsonization in newborn infants and its relationship to parental atopy.
    Richardson VF; Larcher VF; Price JF
    Clin Exp Immunol; 1982 May; 48(2):411-6. PubMed ID: 7049453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An abnormality of the alternate pathway of complement activation in sickle-cell disease.
    Johnston RB; Newman SL; Struth AG
    N Engl J Med; 1973 Apr; 288(16):803-8. PubMed ID: 4144343
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of C3b deposition on yeast surfaces by sera of known opsonic potential.
    Turner MW; Mowbray JF; Roberton DR
    Clin Exp Immunol; 1981 Nov; 46(2):412-9. PubMed ID: 7039889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast opsonization and phagocytosis studied by a visual assay and measurement of neutrophil chemiluminescence.
    Vernon J; Kemp AS; Van Asperen PP; Worsdall P; Roy LP
    J Clin Lab Immunol; 1984 Jun; 14(2):93-7. PubMed ID: 6748051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of complement components on the size and the opsonization of DNA-anti-DNA complexes.
    Lamers MC; De Groot ER; Daha MR; Roos D
    Scand J Immunol; 1982 Nov; 16(5):389-401. PubMed ID: 7178842
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.
    Wyke RJ; Rajkovic IA; Eddleston AL; Williams R
    Gut; 1980 Aug; 21(8):643-9. PubMed ID: 7000632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement dependent phagocytosis in idiopathic nephrotic syndrome and in healthy controls].
    Forsgren A
    Lakartidningen; 1975 Jul; 72(28-29):2876-9. PubMed ID: 1142933
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.
    Roberton DM; Dhanjal NK; Levinsky RJ; Mowbray JF; Turner MW
    Clin Exp Immunol; 1981 Jan; 43(1):208-14. PubMed ID: 7018758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes.
    Czop JK; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1132-8. PubMed ID: 641341
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective serum opsonization activity in children aged 6-48 months having acute purulent otitis media.
    Tezcan I; Yilmaz Y; Oner F; Yel L; Sanal O; Ersoy F; Onerci M; Berkel AI
    Turk J Pediatr; 1997; 39(4):453-7. PubMed ID: 9433146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.
    Yeaman GR; Kerr MA
    Clin Exp Immunol; 1987 Apr; 68(1):200-8. PubMed ID: 3308208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.
    Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD
    Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization.
    Peltier AP
    Nouv Rev Fr Hematol; 1974; 14(2):247-57. PubMed ID: 4277246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.